Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
thonzonium
- Development stage
- Unknown
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Otic, Intranasal
01
Overview
Thonzonium is a monocationic surface-active agent (cationic surfactant) primarily used as an additive in otic (ear) and nasal pharmaceutical formulations. Its main function is to disperse exudate and cellular debris, thereby enhancing the penetration and tissue contact of co-administered active ingredients such as antibiotics or corticosteroids[2][6][7]. Thonzonium bromide is a component of FDA-approved products like Cortisporin TC and Coly-Mycin S Otic, which are indicated for the treatment of superficial bacterial infections of the external auditory canal and infections following ear surgery[3][4][5]. Mechanistically, thonzonium acts by uncoupling vacuolar ATPase in pathogenic fungi, inhibiting RANKL-induced osteoclast formation (anti-resorptive effect), and has been shown to inhibit SARS-CoV-2 3CL protease with potential broad-spectrum antiviral activity[2][5][8].
- Brand names
- Cortisporin TCColy-Mycin S
- Other names
- thonzonium bromide
02
Targets
Mpro (3C-like proteinase of SARS-CoV-2)V-ATPase (Vacuolar-type H+-ATPase)RANKL (Receptor Activator for Nuclear Factor-kappa B Ligand)
Beyond the preview
Go deeper on thonzonium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on thonzonium.